Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
Abstract Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d01fd21c42fb47f7bb59d61136ca06e3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|